Pfizer COVID Vax Performs Well in Youth With Rheumatic Diseases

Nearly all participants in the study showed complete seroconversion, in contrast to similar studies in adults.

Related Keywords

University Of Pennsylvania ,Pennsylvania ,United States ,Israel ,Philadelphia ,Slovenia ,Melissa Oliver ,Merav Heshin Bekenstein ,Bethh Rutstein ,Pfizer ,Rheumatology Research Alliance ,Tel Aviv Sourasky Medical Center ,American College Of Rheumatology ,Perelman School Of Medicine ,Childhood Arthritis ,Dana Dwek Children ,Pediatric Rheumatology ,Indiana University School ,Perelman School ,Included Diverse Conditions ,Effects Similar ,Response High ,Patients With Rheumatic ,American College ,Presented May ,Covid 19 Vaccine ,Coronavirus Vaccine ,Rheumatic Disease ,Vaccine ,Arthritis ,Oint Inflammation ,Young Adult ,Adverse Effects ,Side Effects ,Asthma ,Sthmatic ,Patient Safety ,Arthralgia ,Ainful Joint ,Joint Pain ,Systemic Lupus Erythematosus ,Sale ,Systemic Sclerosis ,Diffuse Scleroderma ,Adolescent Medicine ,Coronavirus ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Shuman Co ,